- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Imatinib Mesylate (Gleevec)
Total 2810 results
-
Shanghai Zhongshan HospitalChanghai Hospital; Fudan University; Huashan Hospital; Ruijin Hospital; Shanghai...UnknownMethod of Differentiating Benignancy and Malignancy, Grading and Staging for GISTChina
-
Novartis PharmaceuticalsCompletedChronic Myeloid LeukemiaChina
-
Novartis PharmaceuticalsCompleted
-
University Hospital, BordeauxCompletedMyeloid Leukemia, ChronicFrance
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedLeukemiaUnited States
-
Keio UniversityMerck Sharp & Dohme LLC; Ohara Pharmaceutical Co., Ltd.Recruiting
-
University Hospital, BordeauxCompleted
-
NovartisCompleted
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Novartis PharmaceuticalsTerminatedPulmonary Arterial HypertensionSpain, Germany, Belgium, Switzerland, United States, Netherlands, Austria, Canada, Korea, Republic of, Italy, Japan, United Kingdom, France
-
Novartis PharmaceuticalsTerminatedPulmonary Arterial HypertensionGermany, Belgium, United Kingdom, United States, Lithuania, Italy, Australia
-
Novartis PharmaceuticalsCompletedGastrointestinal Stromal TumorsUnited States, France, Italy
-
Novartis PharmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLung CancerUnited States
-
NovartisTerminatedRecurrent Glioblastoma Multiforme (GBM)United States
-
First Affiliated Hospital of Zhejiang UniversityZhejiang Cancer Hospital; Second Affiliated Hospital, School of Medicine, Zhejiang... and other collaboratorsRecruitingGastrointestinal Stromal Tumor | Progression-free Survival | NeoadjuvantChina
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Myelomonocytic Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Seoul St. Mary's HospitalMinistry of Health & Welfare, KoreaUnknownChronic Myeloid Leukemia | Imatinib | Complete Molecular ResponseKorea, Republic of
-
Asan Medical CenterWithdrawnGastrointestinal Stromal Tumors
-
Novartis PharmaceuticalsTerminatedGastrointestinal Stromal TumorsChina, Argentina, Russian Federation, Thailand, Korea, Republic of, Brazil, Canada, Venezuela, Mexico
-
Nantes University HospitalCompleted
-
Xijing HospitalRecruiting
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruitingChronyc Myeloid LeukemiaNetherlands, Italy
-
University of Sao Paulo General HospitalUnknownLeukemia, Myeloid, Chronic-PhaseBrazil
-
University of Auckland, New ZealandLeukaemia & Blood Cancer New ZealandActive, not recruiting
-
Xiangya Hospital of Central South UniversityCompletedGastrointestinal Stromal Tumor, MalignantChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Estrogen Receptor Positive | Progesterone Receptor Positive | Postmenopausal | KIT Positive | PDGFR PositiveUnited States
-
Oslo University HospitalSuspendedGastrointestinal Stromal TumorNorway
-
Imperial College LondonNovartis PharmaceuticalsCompletedChronic Myeloid Leukemia | Newly DiagnosedUnited Kingdom
-
Bristol-Myers SquibbTerminatedLeukemia, Myeloid, ChronicSweden, United Kingdom, Russian Federation, France, Germany, Belgium, Portugal, Finland, Norway, Spain, Italy
-
PfizerCompletedLeukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) PositiveFrance, United States, Canada, Spain, Czechia, Singapore, Thailand, Denmark, Norway, Korea, Republic of, Finland, Hungary, Sweden, Netherlands, Italy, Germany, Ukraine, South Africa, Taiwan, Australia, Belgium, Israel, Mexico, Poland, S... and more
-
Hikma Pharmaceuticals LLCCompletedChronic Myeloid Leukemia, Chronic PhaseJordan
-
University of BolognaCompleted
-
MedPacto, Inc.Recruiting
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedStem Cell Transplantation | TreatmentItaly
-
Elevar TherapeuticsCompleted
-
M.D. Anderson Cancer CenterThe Vaccine CompanyTerminated
-
Hyo Song KimActive, not recruitingDesmoid TumorKorea, Republic of
-
Novartis PharmaceuticalsCompletedMyelogenous Leukemia, ChronicSouth Africa, Italy, Belgium, Japan, Taiwan, Turkey, Canada, Germany, Spain, Egypt, United States, Singapore, Austria, France, Netherlands, Sweden, United Kingdom, Korea, Republic of, Hong Kong, Thailand, Russian Federation, Brazil, Hungar... and more
-
Bristol-Myers SquibbTerminated
-
University of PittsburghNovartisCompleted
-
Novartis PharmaceuticalsCompletedImatinib | CMLKorea, Republic of
-
Hikma Pharmaceuticals LLCCompletedPhiladelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic PhaseEgypt
-
Alexandria UniversityScience, Technology & Innovation Funding Authority (STIFA), EgyptUnknown
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingMinimal Residual Disease | Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedMinimal Residual Disease | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive in RemissionUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Melanoma | Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Unresectable Melanoma | C-KIT Tyrosine Kinase Protein Overexpression | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Gastrointestinal Stromal Tumor | Pathologic Stage IV Cutaneous Melanoma... and other conditionsUnited States